Another patient, a 21-year-old male who was diagnosed at the age of 10 years with an ACTH-secreting pituitary microadenoma, at age 16 years developed MTC and was found to have MEN2B with the characteristic M918T RET proto-oncogene variant [9]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.